Vacuum-assisted biopsy devices (VABD) have brought a gradual shift in breast diseases' surgical treatment due to the popularization of minimally invasive procedures. VABD has an expanding role in the surgical treatment of benign breast cancer or diseases. Further improvement in technology has extend its therapeutic role to the excision of small malignant lesions.

NORTH AMERICA DOMINATED WITH OVER 40% SHARE IN 2019.
Mounting breast cancer burden and rising preferences for minimally invasive treatments drive the regional market. About 1 in 8 U.S. women will develop invasive breast cancer throughout their lifetime. As per the American Cancer Society's estimates, about 281,550 new cases of breast cancer will be diagnosed in women in the United States for 2021. The growth is also attributed to prominent players' presence, increasing R&D trials, increased awareness, and advanced therapeutics adoption.
BY APPLICATION, HOSPITALS ACCOUNTED FOR OVER 50% SHARE IN 2019.
Rising therapeutics and diagnosis of breast cancer patients drive segment growth. Vacuum-assisted biopsy devices are increasingly employed across hospitals to diagnose nature of malignant and take away a sample of abnormal breast tissue. VABB is considered highly précised for diagnosing suspicious breast lesions and is highly successful at treating presumed benign breast lesions. Growing expenditure to treat breast cancer and expanding breast cancer specialist infrastructure is projected to create new volume calls.
PROMINENT PLAYERS IN THE MARKET:
BD, Mammotome, and Hologic
The global demand for Vacuum Assisted Biopsy Devices Market was valued around USD 395 million in 2022 and grow with a CAGR of 10% between 2023-2030.
A vacuum-assisted core biopsy device (VABD) is a minimally invasive breast biopsy used as a standard diagnostic or therapeutic technique for breast tumours. It uses a suction system and image guidance such as x-ray, ultrasound, and MRI to perform breast biopsies, which allows a larger tissue sample to be obtained from a single insertion. Vacuum-assisted biopsy is considered more comfortable to perform as it uses a thinner and lighter needle, non-tethered system. The procedure is performed under local anaesthesia. The vacuum-assisted biopsy device was initially launched as a diagnostic tool; however, later improvement in technology has now extended its role for therapeutic procedures.
Market Dynamics
Rising breast cancer prevalence and growing demand for minimally invasive treatments drive the global vacuum-assisted biopsy devices market. Breast cancer is the second frequent cancer worldwide. Several studies have forecasted that the incidence of breast cancer cases is expected to swell in the coming years, largely the result of an aging population. The breast cancer therapeutics market is rapidly evolving and presenting new commercial opportunities for the vacuum-assisted biopsy devices market. A biopsy device with integrated vacuum technology offers untethered freedom during an ultrasound breast biopsy. It offers more control, better access, consistent cores, fewer needle insertions, and a more compassionate breast biopsy. Currently, handful VAB systems are available. Players are focused on launching updated systems with extended performance. However, the availability of other alternatives and some procedure limitations are estimated to hamper the global vacuum-assisted biopsy devices market's growth.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of vacuum assisted biopsy devices.
Market Segmentation
The entire Vacuum Assisted Biopsy Devices market has been sub-categorized into classification, applications. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Type
By Applications
- Hospitals
- Academic and Research Institutes
- Diagnostic and Imaging Centers
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for vacuum assisted biopsy devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Vacuum Assisted Biopsy Devices Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the vacuum assisted biopsy devices market include BD, Mammotome, Hologic. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.